Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Normalization of the tumor vasculature through oncogenic inhibition: an emerging paradigm in tumor biology.

Normalization of the tumor vasculature through oncogenic inhibition: an emerging paradigm in tumor biology. Proc Natl Acad Sci U S A. 2012 May 15; 109(20):E1214.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.